Market Overview

Benzinga's Top #PreMarket Losers

Related NLNK
NewLink Genetics Presents Phase 1b Data of Indoximod in Combination With Gemcitabine/Nab-Paclitaxel
15 Biotechs Making Announcements At The 2015 Piper Jaffray Healthcare Conference
First Eagle Investment Increases Flowserve Holding by 14% (GuruFocus)
Salesforce And FireEye Traders Continue To Lower Price Points They're Watching
FireEye Upgraded By BTIG, Firm Sees 'Clear Path' To Positive Free Cash Flow
Key CyberSecurity Stocks Reporting Earnings and Other News (Small Cap Network)

Analogic (NASDAQ: ALOG) shares dropped 11.20% to $85.75 in pre-market trading after the company reported downbeat Q2 earnings.

NewLink Genetics (NASDAQ: NLNK) shares fell 7.14% to $35.00 in the pre-market trading after the company's independent review committee recommended the study continuation without modification after completion of first interim analysis of IMPRESS Phase 3 pancreatic cancer trial with algenpantucel-L.

FireEye (NASDAQ: FEYE) dipped 6.71% to $83.54 after the company priced its follow-on public offering of 14 million shares at $82.00 per share.

The Gap (NYSE: GPS) dipped 3.64% to $40.75 in the pre-market session after the company reported a 7% drop in its February same-store sales. However, analysts were expecting a 1.1% rise in same-store sales.

Posted-In: PreMarket LosersNews Movers & Shakers Pre-Market Outlook Markets


Related Articles (ALOG + FEYE)

View Comments and Join the Discussion!

Get Benzinga's Newsletters